Melissa Mae Rhodes

US Patent:

20080103530, May 1, 2008

Filed:

Oct 31, 2006

Appl. No.:

11/554825

Inventors:

Holly S. Vitense - Maple Grove MN, US
Li Wang - Hong Kong, CN
Denise Dirnberger - Blaine MN, US
Melissa M. Rhodes - Columbia Heights MN, US
Douglas A. Hettrick - Andover MN, US
Shantanu Sarkar - St. Paul MN, US

International Classification:

A61N 1/00

US Classification:

607 2

Abstract:

The capability to suspend a patient alert relating to a monitored physiologic parameters addresses a need to selectively shut off a patient-alert signal or signals during the time a patient is being treated for an excursion in the parameter. Of course, in general a signal call attention to a patient's a potentially deleterious status or condition for which they should seek medical attention. Once a chronically-implanted monitoring device has detected or provided information about the parameter relative to a desired value, trend, or range and a clinician has been notified and intervened the alert signal is temporarily disabled for a predetermined period. That is, once the notification occurs and alert has served its purpose, the alert mechanism is selectively deactivated while the patient ostensibly begins to gradually correct the monitored physiologic parameter under a caregiver's direction and control. After which time, the alert will reactivate.

US Patent:

20120303085, Nov 29, 2012

Filed:

Aug 9, 2012

Appl. No.:

13/570858

Inventors:

Holly S. Vitense - Maple Grove MN, US
Li Wang - Hong Kong, CN
Denise Dirnberger - Blaine MN, US
Melissa M. Rhodes - Columbia Heights MN, US
Douglas A. Hettrick - Andover MN, US
Shantanu Sarkar - St. Paul MN, US

Assignee:

Medtronic, Inc. - Minneapolis MN

International Classification:

A61N 1/365

US Classification:

607 28

Abstract:

The capability to suspend a patient alert relating to a monitored physiologic parameters addresses a need to selectively shut off a patient-alert signal or signals during the time a patient is being treated for an excursion in the parameter. Of course, in general a signal call attention to a patient's a potentially deleterious status or condition for which they should seek medical attention. Once a chronically-implanted monitoring device has detected or provided information about the parameter relative to a desired value, trend, or range and a clinician has been notified and intervened the alert signal is temporarily disabled for a predetermined period. That is, once the notification occurs and alert has served its purpose, the alert mechanism is selectively deactivated while the patient ostensibly begins to gradually correct the monitored physiologic parameter under a caregiver's direction and control. After which time, the alert will reactivate.

US Patent:

20220240828, Aug 4, 2022

Filed:

Apr 15, 2022

Appl. No.:

17/721567

Inventors:

- Minneapolis MN, US
Karen Kleckner - Blaine MN, US
Melissa Rhodes - Columbia Heights MN, US
D'Anne Kudlik - Lino Lakes MN, US
Jordyn Reich - Minneapolis MN, US
Keelia Doyle - Minneapolis MN, US
Joshua Blauer - White Bear Lake MN, US

International Classification:

A61B 5/282
A61N 1/362
A61N 1/37
A61N 1/372
A61N 1/39

Abstract:

Systems, interfaces, and methods are described herein for evaluation and adjustment cardiac therapy. The systems, interfaces, and methods may utilize, or include, a graphical user interface to display various information with respect to a plurality of external electrodes and electrical activity monitored using such external electrodes and to allow a user to adjust what information to display.

US Patent:

20190365271, Dec 5, 2019

Filed:

Jun 1, 2018

Appl. No.:

15/995661

Inventors:

- Minneapolis MN, US
Karen Kleckner - Blaine MN, US
Melissa Rhodes - Columbia Heights MN, US
Jordyn Reich - Minneapolis MN, US

International Classification:

A61B 5/0408
A61N 1/37
A61N 1/372
A61N 1/362
A61N 1/39

Abstract:

Systems, interfaces, and methods are described herein for evaluation and adjustment cardiac therapy. The systems, interfaces, and methods may utilize, or include, a graphical user interface to display various information with respect to a plurality of external electrodes and electrical activity monitored using such external electrodes and to allow a user to adjust what information to display.

US Patent:

20190366106, Dec 5, 2019

Filed:

Jun 1, 2018

Appl. No.:

15/995406

Inventors:

- Minneapolis MN, US
Karen Kleckner - Blaine MN, US
Melissa Rhodes - Columbia Heights MN, US
D'Anne Kudlik - Lino Lakes MN, US
Jordyn Reich - Minneapolis MN, US
Keelia Doyle - Minneapolis MN, US
Joshua Blauer - White Bear Lake MN, US

International Classification:

A61N 1/372
A61B 5/00
A61B 5/044
A61B 5/0452
A61B 17/34
A61B 5/0408
A61B 34/20
A61N 1/02
A61N 1/365
A61N 1/368
A61N 1/39

Abstract:

Systems, interfaces, and methods are described herein for evaluation and adjustment cardiac therapy. The systems, interfaces, and methods may utilize, or include, a graphical user interface to display various information with respect to a plurality of external electrodes and electrical activity monitored using such external electrodes and to allow a user to adjust what information to display.

US Patent:

20190030331, Jan 31, 2019

Filed:

Jul 27, 2018

Appl. No.:

16/047619

Inventors:

- Minneapolis MN, US
D'Anne E. Kudlik - Lino Lakes MN, US
Karen J. Kleckner - Blaine MN, US
Melissa M. Rhodes - Columbia Heights MN, US
Keelia Doyle - Minneapolis MN, US

International Classification:

A61N 1/36
A61B 5/0456
A61N 1/32
A61N 1/368
A61B 5/0472

Abstract:

Systems and methods are described herein for selection of a cardiac cycle, or heartbeat, from a plurality of cardiac cycles monitored over time. The cardiac cycle may be selected using various metrics including a single-cycle metric and a cycle-series metric. Further, the selected cardiac cycle may be used for further cardiac analysis (for example, to generate electrical activation times).